Mark Ferguson, Director of of SFI Science Foundation Ireland, photographed in the Science Gallery, Dublin. Photograph: Bryan O’Brien/Irish Times

More than €1.7 million in funding has been made available to support twenty new high-potenial industry-academia partnerships. The funding, whic(...)

Mark Ferguson, Director of of SFI Science Foundation Ireland, photographed in the Science Gallery, Dublin. Photograph: Bryan O’Brien/Irish Times

More than €1.7 million in funding has been made available to support twenty new high-potenial industry-academia partnerships.The funding, which is bei(...)

The Orbsen Therapeutics team. The company has already worked on a number of FP7-funded cell therapy projects

Orbsen Therapeutics, a spin-out from NUI Galway’s Regenerative Medicine Institute (Remedi) has announced plans to partner with the University o(...)

The Orbsen Therapeutics team: the next steps for the company are to continue to raise small amounts of domestic private equity and funding to finance operational costs as it moves towards completion of early stage clinical trials

Breakthroughs in stem cell research tend to be announced with quite some fanfare but this was very deliberately not the case with Orbsen Therapeutics.(...)

Pat Daly, Principal Research Officer, Teagasc, with Liam Kavanagh, MD of the Irish Times; Timothy Brundle, Director of Innovation University of Ulster; Dr Marion Boland, Head of Post Award Programmes Directorate, Science Foundation Ireland; Aidan Gough, Strategy and Policy Director, InterTrade Ireland; Professor Frank Roche, Deputy College Principal, UCD Michael Smurfit Graduate Business School,  in the Irish Times Building on Tara Street Dublin for the first round of the Irish Times/ InterTradeIreland Innovation Awards 2014.  Photograph: David Sleator

The 18 finalists in this year’s Irish Times InterTradeIreland Innovation awards comprise a varied mix of start-ups, third-level spin-offs, and well-es(...)